World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
127
Citations
99215
World Ranking
2758
National Ranking
1540

Overview

Richard I. Fisher is affiliated with Fox Chase Cancer Center in the United States. Their research primarily spans the field of Medicine, with a particular focus on Oncology. Subfields of study include Pathology and Forensic Medicine, Neurology, Pulmonary and Respiratory Medicine, and Genetics.

The scientist has contributed to multiple topics within their discipline. These topics include:

  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • COVID-19 and healthcare impacts
  • Sarcoma Diagnosis and Treatment
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Inflammation biomarkers and pathways
  • CAR-T cell therapy research

Recent publications by Richard I. Fisher highlight a range of cancer-related and clinical research topics. Notable papers include:

  • "A War on Two Fronts: Cancer Care in the Time of COVID-19," 2020, published in Annals of Internal Medicine
  • "Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001," 2020, Journal of Clinical Oncology
  • "Improving Goal Concordant Care Among 10 Leading Academic U.S. Cancer Hospitals: A Collaboration of the Alliance of Dedicated Cancer Centers," 2021, The Oncologist
  • "Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine," 2022, Journal of the National Comprehensive Cancer Network
  • "Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma," 2023, Blood Advances

Frequent coauthors reflect ongoing collaborations across cancer research and oncology. These include:

  • Jonathan W. Friedberg (4 coauthored works)
  • Louis S. Constine (3)
  • Brad S. Kahl (3)
  • Michael LeBlanc (3)
  • Lisa M. Rimsza (3)

The scientist's work is regularly published in a select group of venues with repeated contributions to:

  • Blood
  • UNC Libraries
  • Annals of Internal Medicine
  • Journal of Clinical Oncology
  • The Oncologist

Best Publications

  • A predictive model for aggressive non-Hodgkin's lymphoma

    M. A. Shipp;D. P. Harrington;J. R. Anderson;J. O. Armitage

  • Revised response criteria for malignant lymphoma

    Bruce D. Cheson;Beate Pfistner;Malik E. Juweid;Randy D. Gascoyne

  • Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

    Bruce D. Cheson;Richard I. Fisher;Sally F. Barrington;Franco Cavalli

  • The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors

  • Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

    B D Cheson;S J Horning;B Coiffier;M A Shipp

  • Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma

    Richard I. Fisher;Ellen R. Gaynor;Steve Dahlberg;Martin M. Oken

  • High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993

    Michael B. Atkins;Michael T. Lotze;Janice P. Dutcher;Richard I. Fisher

  • Follicular lymphoma international prognostic index.

    Philippe Solal-Céligny;Pascal Roy;Philippe Colombat;Josephine White

  • Stromal gene signatures in large-B-cell lymphomas

    G Lenz;G Wright;S S Dave;W Xiao

  • Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

    R. Eric Davis;Vu N. Ngo;Georg Lenz;Pavel Tolar

  • Oncogenically active MYD88 mutations in human lymphoma

    Vu N. Ngo;Vu N. Ngo;Ryan M. Young;Roland Schmitz;Sameer Jhavar

  • Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

    Thomas M. Habermann;Edie A. Weller;Vicki A. Morrison;Randy D. Gascoyne

  • Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

    Sandeep S. Dave;George Wright;Bruce Tan;Andreas Rosenwald;Andreas Rosenwald

  • Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

    Gwendolyn Fyfe;Richard I. Fisher;Steven A. Rosenberg;Mario Sznol

  • Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group

    Sally F. Barrington;N. George Mikhaeel;Lale Kostakoglu;Michel Meignan

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

    Thomas P. Miller;Steve Dahlberg;J. Robert Cassady;David J. Adelstein

  • Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.

    Georg Lenz;George W. Wright;N. C.Tolga Emre;Holger Kohlhammer

  • The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

    Andreas Rosenwald;George Wright;Adrian Wiestner;Wing C. Chan;Wing C. Chan

  • Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.

    L J Swinnen;M R Costanzo-Nordin;S G Fisher;E J O'Sullivan;E J O'Sullivan

Frequent Co-Authors

Jonathan W. Friedberg
Jonathan W. Friedberg University of Rochester
Thomas P. Miller
Thomas P. Miller University of Arizona
Lisa M. Rimsza
Lisa M. Rimsza Mayo Clinic
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency
Oliver W. Press
Oliver W. Press University of Washington
Robert C. Young
Robert C. Young Cornell University
Joseph M. Connors
Joseph M. Connors University of British Columbia
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Elias Campo
Elias Campo University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine, a variety of online degrees open new doors to healthcare careers. Many choose to advance their education beyond the MD by exploring specialized and administrative roles.

For those passionate about mental health, online msn pmhnp programs prepare nurses for advanced psychiatric care positions with flexible, accelerated learning options.

Individuals interested in the management side of healthcare can pursue healthcare administration degrees entirely online. These programs cover business, policy, and leadership concepts, ideal for those aiming to influence healthcare delivery systems.

Graduate students seeking higher-level administrative roles can consider an affordable mha online, combining advanced managerial training with cost-effective tuition choices.

Nurses ready for leadership or academic positions may benefit from cheap online dnp programs. These provide a practical route to doctoral-level expertise without high costs.

Whether you are planning direct patient care, mental health specialization, or healthcare management, online pathways offer affordable and flexible options for every stage of your journey.

Best Scientists Citing Richard I. Fisher

Trending Scientists